Bibliography

Found 924 results
2016
Saing T, Lagman M, Castrillon J, Gutierrez E, Guilford FT, Venketaraman V. Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process. BBA Clinical. 2016 ;6:38-44.
Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre S, Ellis RJ, Heaton RK, Franklin D, Barnholtz-Sloan JS, et al. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era. J Infect Dis. 2016 ;213(7):1065-73.
Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JAshley, Letendre S, Ellis RJ, Clifford DB, et al. Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals. J Neurovirol. 2016 ;22(5):607-614.
Dever SM, Rodriguez M, El-Hage N. B-Adrenergic receptor gene expression in HIV-associate neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. Journal of Neurovirology. 2016 .
Gutierrez J, Honig L, Elkind MSV, Mohr JP, Goldman JE, Dwork AJ, Morgello S, Marshall RS. Brain arterial aging and its relationship to Alzheimer Dementia. Neurology. 2016 ;86(16):1507-1515.
Gutierrez J, Menshawy K, Gonzalez M, Elkind MSV, Marshall RS, Dwork AJ, Morgello S. Brain large artery inflammation associated with human immunodeficiency virus and large artery remodeling. AIDS. 2016 ;30(3):415-423.
McGuire JL, Gill AJ, Douglas SD, Kolson DL. The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth. J Neurovirol. 2016 ;22(6):823-830.
Soontornniyomkij V, Kesby JP, Morgan EE, Bischoff-Grethe A, Minassian A, Brown GG, Grant I. Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models. J Neuroimmune Pharmacol. 2016 ;11(3):495-510.
Samuels DC, Kallianpur AR, Ellis RJ, Bush WS, Letendre S, Franklin D, Grant I, Hulgan T. European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection. Pathog Immun. 2016 ;1(2):330-351.
Fields J, Serger E, Campos S, Divakaruni AS, Kim C, Smith K, Trejo M, Adame A, Spencer B, Rockenstein E, et al. HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders. Neurobiol Dis. 2016 ;86:154-69.
Lamers SL, Rose R, Maidji E, Agsalda-Garcia M, Nolan DJ, Fogel GB, Salemi M, Garcia DL, Bracci P, Yong WH, et al. HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads. Journal of Virology. 2016 ;90(20):8968-8983.
Li G-H, Lee MH, Major E, Nath A. HIV infection of astrocytes is detected in vivo by RNAscope and occurs in vitro via a non-classical mechanism. 2016 .
Rose R, Lamers SL, Nolan DJ, Maidji E, Faria NR, Pybus OG, Dollar JJ, Maruniak SA, McAvoy AC, Salemi M, et al. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer. Journal of Virology. 2016 ;90(20):8984-8993.
Avdoshina V, Fields J, Castellano P, Dedoni S, Palchik G, Trejo M, Adame A, Rockenstein E, Eugenin EA, Masliah E, et al. The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons. Neurotox Res. 2016 ;29(4):583-93.
Fan Y, He JJ. HIV-1 Tat induces unfolded protein response and endoplasmic reticulum stress in astrocytes and causes neurotoxicity through glial fibrillary acidic protein (GFAP) activation and aggregation. Journal of Biological Chemistry. 2016 ;291(43):22819-22829.
Wagner GA, Chaillon A, Liu S, Franklin D, Caballero G, Pond SLK, Vaida F, Heaton RK, Letendre S, Grant I, et al. HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. AIDS. 2016 ;30(17):2591-2597.
Berman JW, Carvallo L, Buckner CM, Luers A, Prevedel L, Bennett MV, Eugenin EA. HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS. J Neuroinflammation. 2016 ;13(1):54.
Brouillette M-J, Yuen T, Fellows LK, Cysique LA, Heaton RK, Mayo NE. Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis. PLoS One. 2016 ;11(5):e0155766.
Edén A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, Franklin D, Price RW, Grant I, Letendre S, et al. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS One. 2016 ;11(6):e0157160.

Pages